Neoadjuvant ⁹⁰ Yttrium peptide receptor radionuclide therapy for advanced rectal neuroendocrine tumour: a case report

ANZ J Surg. 2017 Jan;87(1-2):92-93. doi: 10.1111/ans.12854. Epub 2014 Oct 12.

Authors

Jennifer Ryan^{1

2}, Timothy Akhurst³, A Craig Lynch¹, Michael Michael⁴, Alexander G Heriot¹

Affiliations

¹ Department of Cancer Surgery, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
² Department of Surgery, Epworth Healthcare, Melbourne, Victoria, Australia.
³ Department of Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
⁴ Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.

PMID: 25307828
DOI: 10.1111/ans.12854

No abstract available

Publication types

Case Reports

MeSH terms

Biopsy
Colonoscopes
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging*
Neuroendocrine Tumors / diagnosis
Neuroendocrine Tumors / radiotherapy*
Positron-Emission Tomography
Rectal Neoplasms / diagnosis
Rectal Neoplasms / radiotherapy*
Tomography, X-Ray Computed
Yttrium Radioisotopes / therapeutic use*

Substances

Yttrium Radioisotopes